ClinVar Miner

Submissions for variant NM_004771.4(MMP20):c.389C>T (p.Thr130Ile) (rs61730849)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000778295 SCV000914474 likely pathogenic Amelogenesis imperfecta, hypomaturation type, IIA2 2019-01-13 criteria provided, single submitter clinical testing The MMP20 c.389C>T (p.Thr130Ile) missense variant has been reported in three studies in which it is found in a total of four individuals with amelogenesis imperfecta, including in one in a homozygous state and in three in a compound heterozygous state (Gasse et al. 2013; Gasse et al. 2017; Kim et al. 2017). In all studies, one of the unaffected parents was shown to be heterozygous for the variant. Control data are unavailable for this variant which is reported at a frequency of 0.005575 in the European (Finnish) population from the Genome Aggregation Database. Of note, there are two homozygotes reported in the European (non-Finnish) population from this database. In HEK293 cells, the p.Thr130Ile variant showed reduced secretion into the enamel matrix with retention of proteolytic activity, suggesting reduced functional activity of the protein (Kim et al. 2017). Based on the evidence, the p.Thr130Ile variant is likely pathogenic for amelogenesis imperfecta. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.